Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2009
10/01/2009US20090247460 Inhibitor of vascular endothelial cell growth factor
10/01/2009US20090247457 Neurotrophic components of the adnf i complex
10/01/2009US20090247456 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
10/01/2009US20090247455 Isolation of Inhibitors of IRES-Mediated Translation
10/01/2009US20090247451 Therapeutic Compositions for Age-Related Macular Degeneration
10/01/2009US20090246867 Glial mitogenic factors, their preparation and use
10/01/2009US20090246855 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
10/01/2009US20090246854 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same
10/01/2009US20090246852 Therapeutic use of anti-cs1 antibodies
10/01/2009US20090246836 Pgro expression units
10/01/2009US20090246831 Using acid lysis to release translation products from cells
10/01/2009US20090246830 Recombinant influenza viruses for vaccines and gene therapy
10/01/2009US20090246829 Sequence analysis of the tetravalent rotavirus vaccine
10/01/2009US20090246827 Recombinant toxin fragments
10/01/2009US20090246802 Annexin-based apoptosis markers
10/01/2009US20090246793 Cudr as biomarker for cancer progression and therapeutic response
10/01/2009US20090246759 Test and model for inflammatory disease
10/01/2009US20090246283 Repeat Sequence Protein Polymer Nanoparticles Optionally Containing Active Agents and Their Preparation
10/01/2009US20090246282 Recombinant gelatin particles for cell adhesion
10/01/2009US20090246272 Mda-7 proteins and methods of use thereof
10/01/2009US20090246269 Identification and use of gprc variants in the treatment and diagnosis of parkinson's disease
10/01/2009US20090246228 Moraxella catarrhalis Proteins
10/01/2009US20090246220 Constructs for enhancing immune responses
10/01/2009US20090246219 NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN E; pE)
10/01/2009US20090246215 Amyloid beta1-6 antigen arrays
10/01/2009US20090246202 Human Endokine Alpha and Methods of Use
10/01/2009US20090246194 ERYTHROPOIETIN ANALOG-IgG FUSION PROTEINS
10/01/2009US20090246180 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
10/01/2009US20090246150 Antimicrobial composition
10/01/2009US20090242879 Optoelectronic device and method of fabricating the same
10/01/2009US20090242756 Intensified neutral loss tags and use thereof in mass spectrometry
10/01/2009US20090241413 Use of Proteins as an Antifoaming Constituent in Fuels
10/01/2009CA2719707A1 Therapy for vitiligo
10/01/2009CA2719553A1 Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof
10/01/2009CA2719272A1 Methods and compositions for oral administration of proteins
10/01/2009CA2719041A1 Compositions, methods, and kits
10/01/2009CA2718850A1 Compositions and methods related to silicon transport
10/01/2009CA2718146A1 Novel n- and c-terminal substituted antagonistic analogs of gh-rh
10/01/2009CA2717940A1 Algal glycerol-3-phosphate acyltransferase
10/01/2009CA2715816A1 Hematopoietic cells expressing the protein krtcap3 and ligands for the protein krtcap3
09/2009
09/30/2009EP2105504A2 Genes and proteins, and their use
09/30/2009EP2105503A2 Method for the identification and isolation of binding polypeptides from combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains
09/30/2009EP2105502A1 Compositions and methods for the therapy and diagnosis of lung cancer
09/30/2009EP2105449A2 Antagonistic selective binding agents of osteoprotegerin binding protein
09/30/2009EP2105446A2 Cytokine receptor zalpha11
09/30/2009EP2105141A1 Short bioactive peptides and methods for their use
09/30/2009EP2104684A1 Peptides for use in the treatment of obesity
09/30/2009EP2104683A2 Canine thymic stromal lymphopoietin protein and uses thereof
09/30/2009EP2104682A2 Diagnosis and treatment of alzheimer's and other neurodementing diseases
09/30/2009EP2104509A2 Compositions and methods for treating pathologic angiogenesis and vascular permeability
09/30/2009EP2104508A2 Treating acute renal failure with soluble thrombomodulin variants
09/30/2009EP1789442B1 Muteins of fibroblast growth factor 21
09/30/2009EP1739186B1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor
09/30/2009EP1693378B1 Protein nmb1125 and use thereof in pharmaceutical formulations
09/30/2009EP1509605B1 Production of recombinant fragments of muscle acetylcholine receptor and their use for ex vivo immunoadsorption of anti-ach receptor antibodies from myasthenic patients
09/30/2009EP1451322B1 Il-21 antagonists
09/30/2009EP1407007B1 Attenuated circovirus
09/30/2009EP1342085B1 Non-apoptotic forms of cell death and methods of modulation
09/30/2009EP1328297B1 The function of a haptoglobin-haemoglobin receptor and the uses thereof
09/30/2009EP1242122B1 Delivery of proteins across polar epithelial cell layers
09/30/2009EP1240325B1 Il-17 and il-17r homologous polypeptides and therapeutic uses thereof
09/30/2009EP1185655B1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf)
09/30/2009EP1141297B1 Interleukin-17 related mammalian cytokines. polynucleotides encoding them . uses
09/30/2009EP1124974B1 Hypersensitive response elicitor-induced stress resistance
09/30/2009EP0623168B1 T cell epitopes of the major allergens from dermatophagoides (house dust mite)
09/30/2009CN101547934A Process for selectively localizing active ingredients on and in mitochondria and corresponding active ingredients
09/30/2009CN101544983A Rape heat shock protein gene HSP17.8 and application thereof
09/30/2009CN101544982A Novel nucleic acid sequence of gamma-alcohol soluble protein gene and application thereof
09/30/2009CN101544981A Method for preparing bitter melon polypeptide with function of reducing blood sugar bioactivity by gene engineering and application
09/30/2009CN101544965A Coproduction process for extracting various bioactivators from pig placenta
09/30/2009CN101544693A Recombined extrasin alpha 1 two-strand body protein and preparation method thereof
09/30/2009CN101544692A Rousettus leschenaulti leptin and its cDNA sequence
09/30/2009CN101544691A Gene TUD1 for controlling rice height and grain shape and application thereof
09/30/2009CN101544690A Vegetable proteins extracted from P.octandra, preparation method and application thereof
09/30/2009CN101544689A Leptospira vaccine candidate outer membrane protein
09/30/2009CN101544683A Method and substance for keeping fibrinogen activity in thermal treatment
09/30/2009CN100545263C A novel protein, a genes encoding therefor and a method of using the same
09/30/2009CN100545174C Compositions and methods for wt1 specific immunotherapy
09/30/2009CA2660936A1 Gene marker for evaluating genetic ability for carcass weight in bovine and method for evaluating genetic ability for carcass weight using the same
09/29/2009US7596455 Crystallization of IGF-1
09/29/2009US7595440 Plants and seeds of corn variety CV750102
09/29/2009US7595439 Plants and seeds of corn variety CV681470
09/29/2009US7595430 Using mutation in gene associated with monocyte chemoattractant protein-1detect, diagnose, prevent and treat vision disorders
09/29/2009US7595383 Secreted proteins of Mycobacterium tuberculosis and their use as vaccines and diagnostic reagents
09/29/2009US7595379 Monoclonal antibody comprising an antigen binding site that binds specifically to PSCA protein wherein monoclonal antibody comprises the amino acid sequence of the variable heavy chain region and the variable light chain region of antibody secreted by hybridoma assigned A.T.C.C. Accession No.: PTA-6697
09/29/2009US7595376 Poly zinc finger proteins with improved linkers
09/29/2009US7595375 Genetically engineered protein for use as diagnostic tool in gentic analysis
09/29/2009US7595374 Reducing cytotoxicity of eosinophil derived toxins; administering an effective amount of heparin, heparan sulfate, a potent heparanase inhibitor or a polypeptide of this invention
09/29/2009US7595298 Ala-Arg-Nal-Cys-Tyr-Arg-Lys-DLys-Pro-Tyr-Arg-Cit-Cys-Arg; viricide; low cytotoxicity
09/29/2009US7595296 contacting the fibroblasts with one or more of the mutant FGF-1 polypeptides; eatly exceed the wild-type polypeptide in ability to stimulate human fibroblasts to proliferate.
09/29/2009US7595293 Stable pharmaceutical compositions
09/29/2009US7595198 Biotinated macromolecules having protein reactive groups that react with functional groups on proteins including sulfhydryl and amine groups, used in the detection and isolation of targets from heterologous mixtures
09/29/2009US7595190 Transporters and their uses
09/29/2009US7595184 Nitrile hydratase variant
09/29/2009US7595181 From thermophilic microorganisms; active at high temperature
09/29/2009US7595174 Mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins which has antihepatitis activity
09/29/2009US7595173 Producing antimicrobial peptides (AMPs) by using microbes; not necessary to offset the positive charges of multiple copies of AMPs in multimeric constructs; enables the use of a wider range of multimers and carrier peptides
09/29/2009US7595166 Methods of screening modulators of T2R taste receptors
09/29/2009US7595156 Genes for synthesis of FR-008 polyketides
09/29/2009US7595154 tyrosine kinase; screening for inhibitors of PDGFRA; gastrointestinal stromal tumor (GIST)